Cargando…
Outside any therapeutic trial prescription of hydroxychloroquine for hospitalized patients with covid-19 during the first wave of the pandemic: A national inquiry of prescription patterns among French hospitalists
INTRODUCTION: During the first wave of the coronavirus-disease 2019 (covid-19) pandemic in early 2020, hydroxychloroquine (HCQ) was widely prescribed in light of in vitro activity against severe acute respiratory syndrome–coronavirus-2 (SARS-CoV-2). Our objective was to evaluate in early 2020 the ra...
Autores principales: | Bosquet, Antoine, Affo, Comlan, Plaisance, Ludovic, Poenou, Géraldine, Mortier, Emmanuel, Mahé, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782345/ https://www.ncbi.nlm.nih.gov/pubmed/35061735 http://dx.doi.org/10.1371/journal.pone.0261843 |
Ejemplares similares
-
Analysis of hydroxychloroquine prescriptions for COVID‐19 in Japan
por: Watari, Takashi, et al.
Publicado: (2023) -
In Search of the Appropriate Anticoagulant-Associated Bleeding Risk Assessment Model for Cancer-Associated Thrombosis Patients
por: Poénou, Géraldine, et al.
Publicado: (2022) -
Assessment of bleeding risk in cancer patients treated with anticoagulants for venous thromboembolic events
por: Poénou, Géraldine, et al.
Publicado: (2023) -
Hydroxychloroquine for Coronavirus: The Urgent Need for a Moratorium on Prescriptions
por: Shih, Richard D., et al.
Publicado: (2020) -
Ethical issues related to the hydroxychloroquine treatment prescription for Covid-19
por: El Rhazi, K., et al.
Publicado: (2020)